What’s New in Diabetes Care

The eyes have it!

The FDA recently approved the first prescription medication to treat diabetic retinopathy. While laser procedures and surgery are currently the most common treatments, the Lucentis (ranibizumab) injection works by preventin growth of the eye cells that can cause macular degeneration and diabetic retinopathy. For more information, talk with your endocrinologist or ophthalmologist. diabetes

DID YOU KNOW? – Nearly 8 million people in America suffer from some form of retinopathy. 

 

Decrease hypo risk!

Can a basal insulin decrease your risk for lows? Studies funded by pharmaceutical company Sanofi showed that senior patients prescribed Toujeo U-300 (insulin glargine manufactured by Sanofi) had fewer low blood sugars and were able to maintain better control compared with patients using the insulins Levemir, Lantus, and Tresiba. Toujeo is available in a disposable prefilled pen. Check with your prescriber to see if this choice makes sense as part of your plan to treat diabetes.

t-300

Dial it down!

The FDA approved a new version of the Humalog KwikPen for those who need smaller doses of insulin. The Humalog Junior KwikPen dials up insulin in half-until increments and is available in a U-100 concentration.

 

STOP TYPE 2 IN KIDS!

A recent study presented at the 2017 ADA Scientific Sessions examined the risk of developing type 2 diabetes in severely overweight children. The results confirmed that the chances of developing diabetes continue to rise as a children weight rises. What can you do? Consult with a pediatrician or pediatric endocrinologist to develop a plan to lower a kid’s weight.

childhood-obesity_51cbffd0a1290_w1500

 

Lower your cholesterol!

diabetes-and-cholesterol-connectionPeople with type 2 diabetes are more prone to having high levels of LDL (bad) cholesterol, which is commonly treated with a class of durg called statins. Here’s good news: A new study in the Journal of Clinical Endocrinology & Metabolism found that patients with type 2 diabetes and peripheral artery disease who used a statin had a decreased risk for lower extremity amputation. However, patients who used a non-statin therapy did not reduce that risk. Commonly prescribed statins include rosuvastatin, atorvastatin, simvastatin, and pravastatin. These meds are inexpensive. If you have type 2 diabetes and are not using a statin, ask your health care provider if one is appropriate for you.

 

Leave a Reply